These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 3592866

  • 1. Bronchodilator and other pharmacological activities of R-836 (2,5-diethyl-7-(4-thiomorpholino)-1,2,4-triazolo[1,5-c]pyrimidin e).
    Swingle KF, Hammerbeck DM, Schmid JR, Stelzer VL, Reiter MJ, Peterson AM, Wade JJ.
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):255-71. PubMed ID: 3592866
    [Abstract] [Full Text] [Related]

  • 2. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    Howell RE, Sickels BD, Woeppel SL.
    J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
    Yamada N, Yamada K, Takahashi K, Nakao E, Kadowaki S, Umezu K.
    Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
    [Abstract] [Full Text] [Related]

  • 4. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.
    Gan LL, Wang MW, Cheng MS, Pan L.
    Biol Pharm Bull; 2003 Mar; 26(3):323-8. PubMed ID: 12612441
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological and toxicological studies of an original xanthine derivative with bronchodilatating activity.
    Staneva D, Chakurova L, Ivanova N, Spasov V, Raynova L, Bogoslovova T.
    Acta Physiol Pharmacol Bulg; 1984 Mar; 10(4):44-52. PubMed ID: 6535369
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological studies on BB-1502, a new bronchodilator.
    Kamei H, Hirano M, Kawano K, Murata S, Imanishi H, Kawaguchi H.
    Jpn J Pharmacol; 1981 Jun; 31(3):333-46. PubMed ID: 6273627
    [Abstract] [Full Text] [Related]

  • 7. New pharmacological data on the bronchospasmolytic activity of bamifylline.
    Berti F, Magni F, Rossoni G, Schiantarelli P, Bongrani S, Pasargiklian R.
    Arzneimittelforschung; 1988 Jan; 38(1):40-4. PubMed ID: 3365275
    [Abstract] [Full Text] [Related]

  • 8. [Experimental study on the action mechanism of a new bronchodilator agent, BB-1502].
    Kamei H, Obi Y, Kawano K, Hirano M, Murata S, Imanishi H.
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):335-42. PubMed ID: 6200410
    [Abstract] [Full Text] [Related]

  • 9. Comparison of animal models for predicting bronchodilator efficacy in man.
    Spilker B, Minatoya H, McKeon WB.
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):218-35. PubMed ID: 1190917
    [Abstract] [Full Text] [Related]

  • 10. Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig.
    Underwood DC, Bochnowicz S, Osborn RR, Kotzer CJ, Luttmann MA, Hay DW, Gorycki PD, Christensen SB, Torphy TJ.
    J Pharmacol Exp Ther; 1998 Dec; 287(3):988-95. PubMed ID: 9864284
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic potency and selectivity of a new bronchodilator agent, 2,3-dihydro-7-methyl-9-phenyl-1H-pyrazolo [1,2-a] indazolium bromide (FKK) on canine tracheal preparations "in vivo" and "in vitro".
    Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):150-63. PubMed ID: 6870387
    [Abstract] [Full Text] [Related]

  • 12. [Effect of a new bronchodilator, S-1540 (Bitolterol) and S-1541 on the tracheo-bronchial and cardiovascular system].
    Ono N, Kushiku K, Morishita H, Nakagami K, Nakahara T.
    Nihon Yakurigaku Zasshi; 1975 Oct; 71(7):739-52. PubMed ID: 1240071
    [Abstract] [Full Text] [Related]

  • 13. Pharmacologic studies on W10,294A, a new bronchodilator.
    Giles RE, Williams JC, Finkel MP.
    J Pharmacol Exp Ther; 1977 Dec; 203(3):701-11. PubMed ID: 21958
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
    Underwood DC, Osborn RR, Novak LB, Matthews JK, Newsholme SJ, Undem BJ, Hand JM, Torphy TJ.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):306-13. PubMed ID: 8392555
    [Abstract] [Full Text] [Related]

  • 15. [Bronchodilator actions of diltiazem in vitro and in vivo (author's transl)].
    Nagao T, Iwasawa Y, Ikezawa K, Murata S, Sato M.
    Nihon Yakurigaku Zasshi; 1981 May; 77(5):553-8. PubMed ID: 7297962
    [Abstract] [Full Text] [Related]

  • 16. Multiple mechanisms of xanthine actions on airway reactivity.
    Howell RE.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1008-14. PubMed ID: 2175791
    [Abstract] [Full Text] [Related]

  • 17. The effects of methylxanthines, ethymizol, ephedrine and papaverine on guinea pig and dog trachea.
    Bilcíková L, Bauer V, Kolena J.
    Gen Physiol Biophys; 1987 Apr; 6(2):137-48. PubMed ID: 2820837
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium.
    Brunelleschi S, Haye-Legrand I, Labat C, Norel X, Benveniste J, Brink C.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):356-63. PubMed ID: 3478474
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
    Hay DW, Muccitelli RM, Tucker SS, Vickery-Clark LM, Wilson KA, Gleason JG, Hall RF, Wasserman MA, Torphy TJ.
    J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747
    [Abstract] [Full Text] [Related]

  • 20. The use of the in vivo trachea preparation of the guinea-pig to asses drug action on lung.
    James GW.
    J Pharm Pharmacol; 1969 Jun; 21(6):379-86. PubMed ID: 4389171
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.